<DOC>
	<DOCNO>NCT02096276</DOCNO>
	<brief_summary>The purpose Registry detect describe abnormal pregnancy outcome , include teratogenicity , females intentionally unintentionally expose Boostrix pregnancy . The Registry require voluntary , prospective reporting eligible pregnancy patient health care provider ( HCPs ) . Data vaccination Boostrix pregnancy within 28 day precede conception , potential confounding factor ( exposure medication ) information relate outcome pregnancy collect prospectively .</brief_summary>
	<brief_title>Boostrix® Pregnancy Registry</brief_title>
	<detailed_description>The Registry originally initiate 03 May 2005 , part program enhance pharmacovigilance . Following new European Union Pharmacovigilance legislation , pregnancy registry consider post-authorization safety study ( PASS ) . The ongoing Registry therefore convert PASS study . Exposed pregnancy report Registry transition PASS ( 03 May 2005 Q1 2014 ) , data collect analyzed prospectively , also include analysis . Some pregnancy exposure may report pregnancy outcome identify ( retrospective report ) . The Registry capture retrospective report , report include analysis prospective report . Pregnancy outcome data collect use questionnaire within 3 month estimate date delivery ( EDD ) approximately 6 month 12 month EDD ( live birth ) ascertain presence birth defect diagnose , Q1 2014 Q4 2018 .</detailed_description>
	<criteria>A subject include Registry follow criterion meet : Exposure vaccine occur pregnancy within 28 day precede conception Subject US resident A HCP identify ( name , address phone number ) Subject identify ( GSK HCP ) Data register subject included analysis follow criterion meet : • Pregnancy ongoing outcome unknown Data register subject included analysis follow criterion meet : • Outcome pregnancy know time initial report . Types know outcome include prenatal test report result abnormal outside reference range , indicate possible abnormality fetus . Pregnancies prenatal test indicate normal pregnancy would also exclude inclusion pregnancy could potentially bias result toward low overall estimate risk defect . Typically pregnancies &gt; 16 week gestation undergone prenatal test identify whether child congenital abnormality</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pregnancy Registry</keyword>
	<keyword>Boostrix</keyword>
	<keyword>Women</keyword>
	<keyword>Cohort</keyword>
	<keyword>Prospective</keyword>
	<keyword>Pregnancy outcome</keyword>
	<keyword>Exploratory</keyword>
</DOC>